Skip to main content
twitter
facebook
linkedin
Newsroom
Subscribe
Contact
Hit enter to search or ESC to close
Close Search
Menu
About
Company Overview
Team
Careers
Science
Pipeline
Investors
Investor Overview
Press Releases
Events + Presentations
Company Information
SEC Filings
Stock Information
Corporate Governance
News Alerts
Investors
Press Releases
Overview
Press Releases
Events + Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
News Alerts
Recent Press Releases
Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373
March 23, 2023
Enveric Biosciences Establishes Australia-based Subsidiary to Accelerate its Lead Psilocin Prodrug Program Targeting Mental Health Indications
March 21, 2023
Enveric Biosciences Announces Bioproduction Platform Using Novel Cane Toad Enzyme for Psychedelic-Inspired Drug Discovery
March 14, 2023
Enveric Biosciences Appoints Kevin Coveney as Chief Financial Officer, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 28, 2023
Enveric Biosciences Names Lynn Gallant Vice President, Clinical Operations, and Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
February 23, 2023
Enveric Biosciences to Present at the Gravitas Securities Inc. 6th Annual Growth Conference
February 22, 2023
View All Press Releases
Close Menu
About
Company Overview
Team
Careers
Science
Pipeline
Investors
Investor Overview
Press Releases
Events + Presentations
Company Information
SEC Filings
Stock Information
Corporate Governance
News Alerts
Newsroom
Subscribe
Contact